arrow
Back
J

Jonathan W. Riess

uc davis school of medicine

43H-index
535Paper Count
1.4WCitation Count
Published Papers 93
Publication Date
Efficacy of Bioengineered PD-L1 siRNA for Immunotherapy Against Non-Small Cell Lung Cancer Cells
err2026-07-29
err0
errOAAI
errNeelu Batra; Mei-Juan Tu; Su Guan; Jonathan W. Riess; Ai-Ming Yu
errShare
errSave
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)
errCancer
IF5.1
err2026-03-15
err0
errOAAI
errBhatia, Aarti; Chen, Zhengjia; Zhang, Yuji; Bruce, Justine Yang; Arnold, Susanne; Kaur, Varinder; Riess, Jonathan W.; Fenton, Moon; Burtness, Barbara; Saba, Nabil F.; Tara, Harold; Steuer, Conor E.; Shin, Dong M.; Wasp, Garrett; Davis, Thomas H.; Patel, Malini; Schmitz, John C.; Bhateja, Priyanka; Diavolitsis, Virginia; Zandberg, Dan P.; Mitchell, Darrion L.; Kiesel, Brian F.; Kunos, Charles; Gore, Steven D.; Carducci, Michael; Beumer, Jan H.; Owonikoko, Taofeek K.
errShare
errSave
PLASMA LIPIDOMICS AS A NOVEL LIQUID BIOPSY APPROACH FOR GLIOBLASTOMA
err2025-11-01
err0
errOAAI
errAboubechara, John Paul; Liu, Yin; Fiehn, Oliver; Dahabiyeh, Lina; Fragoso, Ruben; Lee, Han; Riess, Jonathan; Hodeify, Rawad; Bloch, Orin; Aboud, Orwa
errShare
errSave
Metabolomic and lipidomic profiling reveals distinct subtypes of IDH-wildtype glioblastoma and shared metabolic features with IDH-mutant astrocytoma grade 4
err2025-11-01
err0
errOAAI
errAboubechara, John Paul; Liu, Yin; Fiehn, Oliver; Dahabiyeh, Lina; Fragoso, Ruben; Riess, Jonathan; Hodeify, Rawad; Bloch, Orin; Patel, Vihar; Aboud, Orwa
errShare
errSave
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
errCancer
IF5.1
err2025-10-29
err0
PREAI
errLiza C. Villaruz MD; Jingxiao Jin MD; Hong Wang PhD; James J. Lee MD, PhD; Jason J. Luke MD; John C. Rhee MD; Saiama N. Waqar MD; Geoffrey I. Shapiro MD, PhD; James Cleary MD, PhD; Diwakar Davar MD; Timothy F. Burns MD, PhD; Rashmi Verma MD; Manik Amin MD; Leonard Appleman MD, PhD; Kristen K. Ciombor MD; Elizabeth J. Davis MD; Jonathan W. Riess MD; E. Claire Dees MD; Edward J. Kim MD, PhD; Dana Cardin MD; Jianxia Guo PhD; Susan M. Christner BS; Joshua Deppas MS; Angelina M. Parise BS; John C. Schmitz PhD; Bella S. Guerrouahen PhD; Michael Suchko BS; Alejandro Contreras MD, PhD; Li Li PhD; Katherine V. Ferry-Galow PhD; Ting-Chia Chang MS; Shahanawaz Jiwani MD, PhD; Christopher J. Bakkenist PhD; Edward Chu MD; Steven D. Gore MD; Jan H. Beumer PharmD, PhD
errShare
errSave
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment
err2025-10-28
err0
errOAAI
errKevin Lu; John Paul Shen; Fernando J. Lopez-Diaz; Alessandro Leal; Isa Mambetsariev; Kaushal Parikh; Antonious Hazim; Brian D. Woodward; Abhinav Madduri; Faisal Khurshid; Jeremy Fricke; Vamsidhar Velcheti; Jonathan W. Riess; Aaron S. Mansfield; Ravi Salgia; Hatim Husain
errShare
errSave
Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase 2 trial
err2025-10-22
err0
PREAI
errJames Chih-Hsin Yang; Yuh-Min Chen; Ullas Batra; Kien Hung Do; Piyada Sitthideatphaiboon; Pongwut Danchaivijitr; KangYun Lee; Jarin Chindaprasirt; Cheng-Ta Yang; GeeChen Chang; Chaiyut Charoentum; Teerapat Ungtrakul; Juan Ignacio Hernandez Moran; Ryan Hartmaier; Ike Igwegbe; Alexander Gont; Matthew Haskins; Wanning Xu; Jonathan W. Riess
errShare
errSave
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report
err2025-10-21
err0
PREAI
errXiuning Le; Christina Baik; Byoung Chul Cho; Jonathan W. Riess; Zofia Piotrowska; Adrianus Johannes de Langen; Sarah B. Goldberg; Jonathan W. Goldman; Noemi Reguart; Yoshimasa Shiraishi; Helen Ambrose; Paula G. Fraenkel; Brayan Merchan Ruiz; Paul E. Smith; Kwan Ho Tang; Helena A. Yu
errShare
errSave
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
err2025-10-20
err0
errOAAI
errM.M. Zheng; Y. Xia; K. Pan; F. Sun; A. Tan; X.R. Dong; H.Y. Tu; L.B. Tang; Y.S. Li; K. Yin; M. Borgeaud; S. Singhal; E. Zhu; J. Zhang; M. Nilsson; J. Wu; D. Gibbons; H. Wakelee; J.W. Neal; J. Lee; A.A. Vaporciyan; W. Ringsurongkawong; H. Tran; R.Z. Zhang; T. Zhang; Q. Zhou; W.Z. Zhong; W. Li; Y.C. Zhang; J.W. Riess; A. Addeo; J.V. Heymach; N. Myall; D. Tan; Y.L. Wu; X. Le
errShare
errSave
Longitudinal Plasma Lipidomics Reveals Distinct Signatures Following Surgery in Patients with Glioblastoma
err2025-10-15
err0
errOAAI
errJohn Paul Aboubechara; Yin Liu; Oliver Fiehn; Lina A. Dahabiyeh; Ruben Fragoso; Han Sung Lee; Jonathan W. Riess; Rawad Hodeify; Orin Bloch; Orwa Aboud
errShare
errSave
The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast
err2025-10-11
err0
errOAAI
errBalazs Halmos; Narjust Florez; Sarah Goldberg; Wade Iams; Xiuning Le; Ticiana Leal; Danny Nguyen; Luis E. Raez; Jonathan W. Riess; Joshua Sabari; David Bjork; Nichelle Stigger; Yichuan Xia; Paul Cifuentes; Denise D’Andrea; Farah Shanoon; Andy L. Johnson; Melissa L. Johnson
errShare
errSave
Squamous Non–Small Cell Lung Cancer: Current and Emerging Treatment Options
err2025-10-06
err0
PREAI
errPaul K. Paik; Jianjun Zhang; Howard (Jack) West; Jonathan W. Riess
errShare
errSave
Actionable mutations and targeted therapy in non-small cell lung cancer among Latin American and Hispanic patients: a systematic literature review of prognosis and meta-analysis
err2025-09-30
err0
PREAI
errCastaneda-Gonzalez, Juan Pablo; Riess, Jonathan W.; Gomez-Gomez, Maria Paula; Cabezas, Daniel Clavijo; Vargas, Merideidy Plazas; Parra-Medina, Rafael
errShare
errSave
Brief Report: Safety of Pulse-dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-mutated Non-small Cell Lung Cancer
err2025-08-06
err0
PREAI
errFangdi Sun; Seema Nagpal; Surbhi Singhal; Joel W. Neal; Heather A. Wakelee; Nathaniel J. Myall; Patrick Bolan; Jonathan W. Riess; David R. Gandara; Millie S. Das
errShare
errSave
Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT
err2025-03-21
err0
errOAAI
errMingels, Clemens; Madani, Mohammad H.; Sen, Fatma; Nalbant, Hande; Riess, Jonathan W.; Abdelhafez, Yasser G.; Ghasemiesfe, Ahmadreza; Rominger, Axel; Guindani, Michele; Badawi, Ramsey D.; Spencer, Benjamin A.; Nardo, Lorenzo
errShare
errSave
Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse Population
err2025-03-13
err0
PREAI
errJuan Pablo Castañeda-González; Rafael Parra-Medina; Jonathan W. Riess; David R. Gandara; Luis G. Carvajal-Carmona
errShare
errSave
A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations
err2025-02-01
err0
errOAAI
errRiess, Jonathan W.; Lara, Matthew S.; Luxardi, Guillaume; de Rodas, Miguel Lopez; Shimoda, Michiko; Kelly, Karen; Lara, Primo N.; Beckett, Laurel; Monjazeb, Arta; Schalper, Kurt A.; Maverakis, Emanual; Gandara, David R.
errShare
errSave
POLE Mutation Associated With Microsatellite Instability and High Tumor Mutational Burden Confers Exquisite Sensitivity to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer: A Case Report and Genomic Database Analysis
err2025-01-01
err0
PREAI
errLara, Matthew S.; Riess, Jonathan W.; Kaleka, Guneet; Borowsky, Alexander; McPherson, John D.; Godoy, Luis A.; Grego, Lorenzo; Lara Jr, Primo N.; Mitsiades, Nicholas
errShare
errSave
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
err2024-12-01
err0
errOAAI
errTsao, Anne S.; Hsieh, Ming-Hui; Koczywas, Marianna; Tu, Janet; Riess, Jonathan; Tanvetyanon, Tawee; Ma, Barbara T.; Zhao, Ying-Qi; Redman, Mary W.; Edelman, Martin J.; Gandara, David R.; Gray, Jhanelle E.; Kelly, Karen L.
errShare
errSave
Glove Phenomenon Detected by Total-Body PET/CT With 68GA-DOTATATE
err2024-10-14
err0
errOAAI
errNalbant, Hande; Mingels, Clemens; Sen, Fatma; Spencer, Benjamin A.; Riess, Jonathan W.; Nardo, Lorenzo
errShare
errSave